NCT05361291View on ClinicalTrials.gov

Evaluation of the Effect of Adding Dexamethasone to 2% Lidocaine

NACompletedINTERVENTIONAL
Enrollment

124

Participants

Timeline

Start Date

February 1, 2020

Primary Completion Date

August 25, 2021

Study Completion Date

August 25, 2021

Conditions
Pulpitis - Irreversible
Interventions
DRUG

Lidocaine Hydrochloride

Inferior alveolar nerve block

Trial Locations (1)

110025

Faculty of Dentistry, Jamia MIliia Islamia, New Delhi

All Listed Sponsors
lead

Jamia Millia Islamia

OTHER

NCT05361291 - Evaluation of the Effect of Adding Dexamethasone to 2% Lidocaine | Biotech Hunter | Biotech Hunter